Expertise in
6
conditions

Michal Feigenberg-Inbar

555 University Avenue, M5G 1X8, 
Toronto, ON, CA 
Expertise in
6
conditions
555 University Avenue, M5G 1X8, 
Toronto, ON, CA 

Overview

Michal Feigenberg-Inbar practices practicing medicine in Toronto, Canada.

Feigenberg-Inbar is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Infantile Refsum Disease, and Glutaric Acidemia Type 2.

They are actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 2 clinical trials.

Locations

555 University Avenue, M5G 1X8, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy
A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drug: SHP611
Study Phase: Phase 2
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Enrollment Status: Completed
Publish Date: September 06, 2019
View 1 Less Clinical Trial

48 Total Publications

Impact of regular physiotherapy intervention on the function and quality of life of pediatric patients diagnosed with Mucopolysaccharidosis.
Impact of regular physiotherapy intervention on the function and quality of life of pediatric patients diagnosed with Mucopolysaccharidosis.
Journal: Molecular genetics and metabolism reports
Published: August 10, 2025

Frequently Asked Questions about Michal Feigenberg-Inbar

Is Michal Feigenberg-Inbar a top-rated expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)?

MediFind is an objective health platform that identifies experts based on real-world data. Michal Feigenberg-Inbar is classified as an Distinguished expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michal Feigenberg-Inbar participate in research or clinical trials?

Yes. Michal Feigenberg-Inbar has published 48 articles and abstracts on conditions like Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). You can view a list of Michal Feigenberg-Inbar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Feigenberg-Inbar's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile